Gemmer Asset Management’s Novo Nordisk NVO Stock Holding History

Gemmer Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-202	Closed	-$11K	–	799
2022 Q1	$11K	Hold	202	–	–	﹤0.01%	677
2021 Q4	$11K	Hold	202	–	–	﹤0.01%	714
2021 Q3	$10K	Hold	202	–	–	﹤0.01%	715
2021 Q2	$8K	Hold	202	–	–	﹤0.01%	897
2021 Q1	$7K	Hold	202	–	–	﹤0.01%	917
2020 Q4	$7K	Hold	202	–	–	﹤0.01%	848
2020 Q3	$7K	Hold	202	–	–	﹤0.01%	749
2020 Q2	$7K	Buy	202 +16	+9%	+$511	﹤0.01%	731
2020 Q1	$6K	Buy	186 +16	+9%	+$476	﹤0.01%	702
2019 Q4	$5K	Sell	170 -24	-12%	-$665	﹤0.01%	965
2019 Q3	$5K	Buy	194 +24	+14%	+$607	﹤0.01%	966
2019 Q2	$4K	Hold	170	–	–	﹤0.01%	1034
2019 Q1	$4K	Hold	170	–	–	﹤0.01%	1087
2018 Q4	$4K	Buy	170 +4	+2%	+$89	﹤0.01%	1006
2018 Q3	$4K	Sell	166 -98	-37%	-$2.39K	﹤0.01%	1083
2018 Q2	$6K	Buy	264 +44	+20%	+$1.05K	﹤0.01%	942
2018 Q1	$5K	Buy	220 +20	+10%	+$525	﹤0.01%	997
2017 Q4	$5K	Buy	+200	New	+$5.09K	﹤0.01%	972

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Gemmer Asset Management's NVO Position: Q2 2022 in Review

Gemmer Asset Management sold out of Novo Nordisk (NVO) in Q2 2022, closing a stake of 202 shares — an estimated $11K sold.

Gemmer Asset Management first reported a position in NVO in Q4 2017 and held it in 18 quarters. The position peaked at $11K in Q1 2022. 933 funds tracked by Wall St. Rank hold NVO as of Q2 2022.

Gemmer Asset Management reported no remaining Novo Nordisk position as of Q2 2022 after selling out during the quarter.
Gemmer Asset Management sold 202 Novo Nordisk shares in Q2 2022, an estimated $11K.
Gemmer Asset Management first reported a position in Novo Nordisk in Q4 2017 and held it in 18 quarters.
Gemmer Asset Management's Novo Nordisk position peaked at $11K in Q1 2022.
933 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2022.

Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.